Recent endemic coronavirus infection is associated with less severe COVID-19

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254 · see citing works

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249 · see citing works

Clinical and immunological features of severe and moderate coronavirus disease 2019

Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750 · see citing works

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222 · see citing works

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S. S., BALK, R. A., Bramley, A. M., Reed, C., Grijalva, C. G., Anderson, E. J., Courtney, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500245 · Cited by 3,353 · see citing works

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984 · see citing works

Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, march 1-30, 2020

Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335 · see citing works

Prevalence of Asymptomatic SARS-CoV-2 Infection

Oran, D. P., & Topol, E. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3012 · Cited by 2,280 · see citing works

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887 · see citing works

Viral dynamics in mild and severe cases of COVID-19

Liu, Y., Yan, L.-M., Wan, L., Xiang, T.-X., Le, A., Liu, J.-M., Peiris, M., Poon, L. L. M., & Zhang, W. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30232-2 · Cited by 1,727 · see citing works

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2598-9 · Cited by 1,310 · see citing works

Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China

Wu, J. T. K., Leung, K. S. M., Bushman, M., Kishore, N., Niehus, R., Salazar, P. M. D., Cowling, B. J., Lipsitch, M., & Leung, G. M. (2020) · Nature Medicine · doi:10.1038/s41591-020-0822-7 · Cited by 1,308 · see citing works

The time course of the immune response to experimental coronavirus infection of man

Callow, K. A., Parry, H. F., Sergeant, M., & Tyrrell, D. A. J. (1990) · Epidemiology and Infection · doi:10.1017/s0950268800048019 · Cited by 598 · see citing works

Broad neutralization of SARS-related viruses by human monoclonal antibodies

Wec, A. Z., Wrapp, D., Herbert, A. S., Maurer, D. P., Haslwanter, D., Sakharkar, M., Jangra, R. K., Dieterle, M. E., Lilov, A., Huang, D., et al. (2020) · Science · doi:10.1126/science.abc7424 · Cited by 520 · see citing works

Lessons for COVID-19 immunity from other coronavirus infections

Sariol, A., & Perlman, S. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.005 · Cited by 317 · see citing works

Integrative Physiology of Pneumonia

Quinton, L. J., Walkey, A. J., & Mizgerd, J. P. (2018) · Physiological Reviews · doi:10.1152/physrev.00032.2017 · Cited by 308 · see citing works

Race/Ethnicity, Underlying Medical Conditions, Homelessness, and Hospitalization Status of Adult Patients with COVID-19 at an Urban Safety-Net Medical Center — Boston, Massachusetts, 2020

Hsu, H., Ashe, E. M., Silverstein, M., Hofman, M., Lange, S. J., Razzaghi, H., Mishuris, R. G., Davidoff, R., Parker, E., Penman‐Aguilar, A., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6927a3 · Cited by 161 · see citing works

Nasal priming by a murine coronavirus provides protective immunity against lethal heterologous virus pneumonia

Hua, X., Vijay, R., Channappanvar, R., Athmer, J., Meyerholz, D. K., Pagedar, N. A., Tilley, S. L., & Perlman, S. M. (2018) · JCI Insight · doi:10.1172/jci.insight.99025 · Cited by 42 · see citing works

Rapid Implementation of a SARS-CoV-2 Diagnostic Quantitative Real-Time PCR Test with Emergency Use Authorization at a Large Academic Safety Net Hospital

Vanuytsel, K., Mithal, A., Giadone, R. M., Yeung, A. K., Matte, T. M., Dowrey, T. W., Werder, R. B., Miller, G. J., Miller, N. S., Andry, C., et al. (2020) · Med · doi:10.1016/j.medj.2020.05.001 · Cited by 14 · see citing works

Adaptive immunity to SARS-CoV-2 and COVID-19

Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860 · see citing works

The T cell immune response against SARS-CoV-2

Moss, P. A. H. (2022) · Nature Immunology · doi:10.1038/s41590-021-01122-w · Cited by 1,205 · see citing works

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2

Swadling, L., Diniz, M. O., Schmidt, N. M., Amin, O. E., Chandran, A., Shaw, E., Pade, C., Gibbons, J. M., Bert, N. L., Tan, A. T., et al. (2021) · Nature · doi:10.1038/s41586-021-04186-8 · Cited by 384 · see citing works

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection

Anderson, E. M., Goodwin, E. C., Verma, A., Arevalo, C. P., Bolton, M. J., Weirick, M. E., Gouma, S., McAllister, C. M., Christensen, S. R., Weaver, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.010 · Cited by 369 · see citing works

Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells

(2021) · doi:10.1126/science.abj9853 · Cited by 327 · see citing works

SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19

Grifoni, A., Sidney, J., Vita, R., Peters, B., Crotty, S., Weiskopf, D., & Sette, A. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.010 · Cited by 314 · see citing works

Correlates of protection against SARS ‐ CoV ‐2 infection and COVID‐19 disease

Goldblatt, D., Alter, G., Crotty, S., & Plotkin, S. A. (2022) · Immunological Reviews · doi:10.1111/imr.13091 · Cited by 290 · see citing works

Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

Loyal, L., Braun, J., Henze, L., Kruse, B., Dingeldey, M., Reimer, U., Kern, F., Schwarz, T., Mangold, M., Unger, C., et al. (2021) · Science · doi:10.1126/science.abh1823 · Cited by 283 · see citing works

Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines

Sette, A., & Crotty, S. (2022) · Immunological Reviews · doi:10.1111/imr.13089 · Cited by 266 · see citing works

Humoral Responses and Serological Assays in SARS-CoV-2 Infections

Galipeau, Y., Greig, M., Liu, C., Driedger, M., & Langlois, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610688 · Cited by 239 · see citing works

Viral persistence, reactivation, and mechanisms of long COVID

Chen, B. K., Jülg, B. D., Mohandas, S., Bradfute, S. B., & RECOVER Mechanistic Pathways Task Force (2023) · eLife · doi:10.7554/elife.86015 · Cited by 195 · see citing works

T Cell Responses to SARS-CoV-2

Sette, A., Sidney, J., & Crotty, S. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-061120 · Cited by 181 · see citing works

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses

Murray, S. M., Ansari, M. A., Frater, J., Klenerman, P., Dunachie, S. J., Barnes, E. J., & Ogbe, A. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00809-x · Cited by 168 · see citing works

Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses

Ortega, N., Ribes, M., Vidal, M., Rubio, R., Aguilar, R., Williams, S. V., Barrios, D., Alonso, S., Hernández-Luis, P., Mitchell, R. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24979-9 · Cited by 166 · see citing works

The Conundrum of Low COVID-19 Mortality Burden in sub-Saharan Africa: Myth or Reality?

Adams, J. A., MacKenzie, M. J., Amegah, A. K., Ezeh, A., Gadanya, M. A., Omigbodun, A. O., Sarki, A. M., Thistle, P., Ziraba, A. K., Stranges, S., et al. (2021) · Global Health Science and Practice · doi:10.9745/ghsp-d-21-00172 · Cited by 150 · see citing works

Antibody and B cell responses to SARS-CoV-2 infection and vaccination

Röltgen, K., & Boyd, S. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.009 · Cited by 136 · see citing works

SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance

Guo, Y., Han, J., Zhang, Y., He, J., Yu, W., Zhang, X., Wu, J., Zhang, S., Kong, Y., Guo, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.877101 · Cited by 116 · see citing works

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals

Butler, S. E., Crowley, A. R., Natarajan, H., Xu, S., Weiner, J. A., Bobak, C. A., Mattox, D. E., Lee, J., Wieland‐Alter, W., Connor, R. I., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.618685 · Cited by 115 · see citing works

SARS-CoV-2 infections in children: Understanding diverse outcomes

Brodin, P. (2022) · Immunity · doi:10.1016/j.immuni.2022.01.014 · Cited by 115 · see citing works

SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic

Bertoletti, A., Bert, N. L., & Tan, A. T. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.008 · Cited by 115 · see citing works

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors

Zsichla, L., & Müller, V. (2023) · Viruses · doi:10.3390/v15010175 · Cited by 113 · see citing works

Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies

Dobaño, C., Santano, R., Jiménez, A., Vidal, M., Chi, J., Melero, N. R., Popovic, M., López-Aladid, R., Fernández‐Barat, L., Tortajada, M., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.02.006 · Cited by 105 · see citing works

Lung-resident memory B cells protect against bacterial pneumonia

Barker, K. A., Etesami, N. S., Shenoy, A. T., Arafa, E. I., Ana, C. L. D., Smith, N. M. S., Martin, I. M. C., Goltry, W. N., Barron, A., Browning, J. L., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141810 · Cited by 101 · see citing works

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination

Grobben, M., van der Straten, K., Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre‐Bosquet, N., Appelman, B., Lavell, A. H. A., van Vught, L. A., Burger, J. A., et al. (2021) · eLife · doi:10.7554/elife.70330 · Cited by 100 · see citing works

Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response

Lin, C.-Y., Wolf, J., Brice, D. C., Sun, Y., Locke, M., Cherry, S., Castellaw, A. H., Wehenkel, M., Crawford, J. C., Zarnitsyna, V. I., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.12.005 · Cited by 99 · see citing works

Cross-Reactive Antibody Against Human Coronavirus OC43 Spike Protein Correlates with Disease Severity in COVID-19 Patients: A Retrospective Study

Guo, L., Wang, Y., Kang, L., Hu, Y., Wang, L., Zhong, J., Chen, H., Ren, L., Gu, X., Wang, G., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1905488 · Cited by 90 · see citing works

Identification of resident memory CD8 + T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue

Niessl, J., Sekine, T., Lange, J., Kónya, V., Forkel, M., Marić, J., Rao, A., Mazzurana, L., Kokkinou, E., Weigel, W., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abk0894 · Cited by 89 · see citing works

Why Does the Severity of COVID-19 Differ With Age?

Zimmermann, P., & Curtis, N. C. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003413 · Cited by 86 · see citing works

Epidemiology, Clinical Significance, and Diagnosis of Respiratory Viruses and Their Co-Infections in the Post-COVID Era

Contes, K. M., & Liu, B. (2025) · Pathogens · doi:10.3390/pathogens14030262 · Cited by 86 · see citing works

In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms

Cankat, S., Demael, M. U., & Swadling, L. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-01116-8 · Cited by 84 · see citing works

Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality

Morgenlander, W. R., Henson, S. N., Monaco, D. R., Chen, A., Littlefield, K. E., Bloch, E. M., Fujimura, E., Ruczinski, I., Crowley, A. R., Natarajan, H., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146927 · Cited by 84 · see citing works

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

Dykema, A. G., Zhang, B., Woldemeskel, B. A., Garliss, C. C., Cheung, L. S., Choudhury, D. M., Zhang, J., Aparicio, L., Bom, S., Rashid, R., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146922 · Cited by 82 · see citing works

Robust and durable serological response following pediatric SARS-CoV-2 infection

Renk, H., Dulovic, A., Seidel, A., Becker, M., Fabricius, D., Zernickel, M., Junker, D., Groß, R. M., Müller, J. A., Hilger, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27595-9 · Cited by 81 · see citing works

Cross-protective immunity following coronavirus vaccination and coronavirus infection

Dangi, T., Palacio, N. M., Sanchez, S., Park, M., Class, J., Visvabharathy, L., Ciucci, T., Koralnik, I. J., Richner, J. M., & Penaloza-MacMaster, P. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151969 · Cited by 78 · see citing works

COVID-19—Lessons Learned and Questions Remaining

Fang, F. C., Benson, C. A., del Rı́o, C., Edwards, K. M., Fowler, V. G., Fredricks, D. N., Limaye, A. P., Murray, B. E., Naggie, S., Pappas, P. G., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1654 · Cited by 77 · see citing works

Evolution of SARS-CoV-2: Review of Mutations, Role of the Host Immune System

Banoun, H. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000515417 · Cited by 75 · see citing works

Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients

Hagemann, K., Riecken, K., Jung, J. M., Hildebrandt, H., Menzel, S., Bunders, M. J., Fehse, B., Koch‐Nolte, F., Heinrich, F., Peine, S., et al. (2022) · European Journal of Immunology · doi:10.1002/eji.202149470 · Cited by 75 · see citing works

T cell immunity to SARS-CoV-2

Niessl, J., Sekine, T., & Buggert, M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101505 · Cited by 74 · see citing works

A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines

Lim, J. M. E., Hang, S. K., Hariharaputran, S., Chia, A., Tan, N., Lee, E. S., Chng, E., Lim, P. L., Young, B. E., Lye, D. C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100793 · Cited by 73 · see citing works

Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers

Antunes, R. D. S., Pallikkuth, S., Williams, E., Yu, E. D., Mateus, J., Quiambao, L. G., Wang, E. W., Rawlings, S. A., Stadlbauer, D., Jiang, K., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab176 · Cited by 70 · see citing works

COVID-19 Mechanisms in the Human Body—What We Know So Far

Kumar, A., Narayan, R. K., Prasoon, P., Kumari, C., Kaur, G., Kumar, S., Kulandhasamy, M., Sesham, K., Pareek, V., Faiq, M. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693938 · Cited by 68 · see citing works

The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role

Bertoletti, A., Tan, A. T., & Bert, N. L. (2021) · Oxford Open Immunology · doi:10.1093/oxfimm/iqab006 · Cited by 67 · see citing works

Immune imprinting and next-generation coronavirus vaccines

Huang, C. Q., Vishwanath, S., Carnell, G., Chan, A. C. Y., & Heeney, J. L. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01505-9 · Cited by 66 · see citing works

Defending against SARS-CoV-2: The T cell perspective

Almendro-Vázquez, P., Laguna‐Goya, R., & Paz‐Artal, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1107803 · Cited by 64 · see citing works

Instructing durable humoral immunity for COVID-19 and other vaccinable diseases

Bhattacharya, D. (2022) · Immunity · doi:10.1016/j.immuni.2022.05.004 · Cited by 63 · see citing works

T cell immune memory after covid-19 and vaccination

Wang, L., Nicols, A. R., Turtle, L. C. W., Richter, A. G., Duncan, C. J. A., Dunachie, S. J., Klenerman, P., & Payne, R. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000468 · Cited by 61 · see citing works

A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2

Majdoubi, A., Michalski, C., O’Connell, S. E., Dada, S., Narpala, S., Gelinas, J. P., Mehta, D., Cheung, C., Winkler, D. F. H., Basappa, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146316 · Cited by 56 · see citing works

Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post–COVID-19 Convalescent Samples

Shrwani, K. J., Sharma, R. S., Krishnan, M., Jones, T., Neto, M. M., Cantoni, D. M., Temperton, N. J., Dobson, S. L., Subramaniam, K. S., McNamara, P. S., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab333 · Cited by 56 · see citing works

Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)

Dugas, M., Grote-Westrick, T., Vollenberg, R., Lorentzen, E. U., Brix, T. J., Schmidt, H., Tepasse, P., & Kühn, J. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.085 · Cited by 55 · see citing works

Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses

Wratil, P. R., Schmacke, N. A., Karakoc, B., Dulovic, A., Junker, D., Becker, M., Rothbauer, U., Osterman, A., Späth, P. M., Ruhle, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110169 · Cited by 55 · see citing works

Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk

Pérez‐Alós, L., Hansen, C. B., Armenteros, J. J. A., Madsen, J. R., Heftdal, L. D., Hasselbalch, R. B., Pries‐Heje, M. M., Bayarri‐Olmos, R., Jarlhelt, I., Hamm, S. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41342-2 · Cited by 53 · see citing works

Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses

Tan, C. C. S., Owen, C. J., Tham, C. Y. L., Bertoletti, A., van Dorp, L., & Balloux, F. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105075 · Cited by 52 · see citing works

Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2

Galipeau, Y., Siragam, V., Laroche, G., Marion, E., Greig, M., McGuinty, M., Booth, R. A., Durocher, Y., Čuperlović‐Culf, M., Bennett, S. A. L., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103700 · Cited by 50 · see citing works

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike

Crowley, A. R., Natarajan, H., Hederman, A. P., Bobak, C. A., Weiner, J. A., Wieland-Alter, W., Lee, J., Bloch, E. M., Tobian, A. A. R., Redd, A. D., et al. (2022) · eLife · doi:10.7554/elife.75228 · Cited by 49 · see citing works

Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay

Echeverría, G. A., Guevara, A. G., Coloma, J., Ruiz, A. M., Vasquez, M. M., Tejera, E., & de Waard, J. H. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.034 · Cited by 47 · see citing works

The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection

Moga, E., Lynton‐Pons, E., & Domingo, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904686 · Cited by 46 · see citing works

Immunity to SARS-CoV-2: Lessons Learned

FERGIE, J. E., & Srivastava, A. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654165 · Cited by 45 · see citing works

Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.

Montesinos, I., Dahma, H., Wolff, F., Dauby, N., Delaunoy, S., Wuyts, M., Detemmerman, C., Duterme, C., Vandenberg, O., Martin, C., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104988 · Cited by 44 · see citing works

Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions

Meyerowitz, E. A., Sen, P., Schoenfeld, S. R., Neilan, T. G., Frigault, M. J., Stone, J. H., Kim, A. Y., & Mansour, M. K. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1759 · Cited by 44 · see citing works

Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

Dugas, M., Grote-Westrick, T., Merle, U., Fontenay, M., Kremer, A. E., Hanses, F., Vollenberg, R., Lorentzen, E. U., Tiwari‐Heckler, S., Duchemin, J., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104847 · Cited by 44 · see citing works

COVID ‐19 and plasma cells: Is there long‐lived protection?*

Nguyen, D. C., Lamothe, P. A., Woodruff, M. C., Saini, A. S., Faliti, C. E., Sanz, I., & Lee, F. E.-H. (2022) · Immunological Reviews · doi:10.1111/imr.13115 · Cited by 44 · see citing works

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation

Meyers, L. M., Gutiérrez, A. H., Boyle, C., Terry, F. E., McGonnigal, B., Salazar, A. Μ., Princiotta, M. F., Martin, W. D., Groot, A. S. D., & Moise, L. (2021) · npj Vaccines · doi:10.1038/s41541-021-00331-6 · Cited by 43 · see citing works

Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2

Liu, D., Chen, C., Chen, D., Zhu, A., Li, F., Zhuang, Z., Mok, C. K. P., Dai, J., Li, X., Jin, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202820120 · Cited by 41 · see citing works

Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19

Sharma, A., Kontodimas, K., & Bosmann, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.648005 · Cited by 39 · see citing works

The past, current and future epidemiological dynamic of SARS-CoV-2

Balloux, F., Tan, C. C. S., Swadling, L., Richard, D., Jenner, C., Maini, M. K., & van Dorp, L. (2022) · Oxford Open Immunology · doi:10.1093/oxfimm/iqac003 · Cited by 37 · see citing works

Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans

Borrega, R., Nelson, D. K. S., Koval, A. P., Bond, N. G., Heinrich, M. L., Rowland, M. M., Lathigra, R. B., Bush, D. J., Aimukanova, I., Phinney, W. N., et al. (2021) · Viruses · doi:10.3390/v13112325 · Cited by 37 · see citing works

Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms

Cappel, M. A., Cappel, J. A., & Wetter, D. A. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.01.009 · Cited by 36 · see citing works

The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps

Wong, A., Guevara, L. A. B., Goult, E., Briga, M., Krämer, S., Kovacevic, A., Opatowski, L., & de Cellès, M. D. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011167 · Cited by 36 · see citing works

Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review

Shafqat, A., Shafqat, S., Alsalameh, S., Kashir, J., AlKattan, K. M., & Yaqinuddin, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835104 · Cited by 36 · see citing works

Targets and cross-reactivity of human T cell recognition of common cold coronaviruses

Tarke, A., Zhang, Y., Methot, N., Narowski, T. M., Phillips, E. J., Mallal, S. A., Frazier, A., Filaci, G., Weiskopf, D., Dan, J. M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101088 · Cited by 36 · see citing works

Divergent trajectories of antiviral memory after SARS-CoV-2 infection

Tomić, A., Skelly, D., Ogbe, A., O’Connor, D., Pace, M. J., Adland, E., Alexander, F., Ali, M., Allott, K., Ansari, M. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28898-1 · Cited by 35 · see citing works

Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals

Johansson, A. M., Malhotra, U., Kim, Y. G., Gomez, R., Krist, M. P., Wald, A., Koelle, D. M., & Kwok, W. W. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010203 · Cited by 35 · see citing works

Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles

Becerra‐Artiles, A., Calvo‐Calle, J. M., Co, M. D. T., Nanaware, P. P., Cruz, J., Weaver, G. C., Lu, L., Forconi, C. S., Finberg, R. W., Moormann, A. M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110952 · Cited by 35 · see citing works

SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations

Anderson, E. M., Li, S. H., Awofolaju, M., Eilola, T., Goodwin, E. C., Bolton, M. J., Gouma, S., Manzoni, T. B., Hicks, P. D., Goel, R. R., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111496 · Cited by 35 · see citing works

Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination

Karl, V., Hofmann, M., & Thimme, R. (2025) · Journal of Virology · doi:10.1128/jvi.01350-24 · Cited by 34 · see citing works

Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic

Yu, E. D., Narowski, T. M., Wang, E. W., Garrigan, E., Mateus, J., Frazier, A., Weiskopf, D., Grifoni, A., Premkumar, L., Antunes, R. D. S., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.07.012 · Cited by 31 · see citing works

Innate and adaptive immunity to SARS-CoV-2 and predisposing factors

Shen, J., Fan, J., Zhao, Y., Jiang, D., Niu, Z., Zhang, Z., & Cao, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1159326 · Cited by 31 · see citing works

Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration

Gouma, S., Weirick, M. E., Bolton, M. J., Arevalo, C. P., Goodwin, E. C., Anderson, E. M., McAllister, C. M., Christensen, S. R., Dunbar, D., Fiore, D., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.150449 · Cited by 30 · see citing works

Persistence of Functional Memory B Cells Recognizing SARS-CoV-2 Variants Despite Loss of Specific IgG

Winklmeier, S., Eisenhut, K., Taskin, D., Rübsamen, H., Gerhards, R., Schneider, C., Wratil, P. R., Stern, M., Eichhorn, P., Keppler, O. T., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103659 · Cited by 30 · see citing works

Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19

Khoo, W. H., Jackson, K., Phetsouphanh, C., Zaunders, J., Alquicira-Hernández, J., Yazar, S., Ruiz‐Diaz, S., Singh, M., Dhenni, R., Kyaw, W., et al. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109209 · Cited by 30 · see citing works

The Integrated Pulmonary Immune Response to Pneumonia

Traber, K. E., & Mizgerd, J. P. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082323-031642 · Cited by 29 · see citing works

Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study

Sealy, R. E., & Hurwitz, J. L. (2021) · Microorganisms · doi:10.3390/microorganisms9081643 · Cited by 29 · see citing works

Global Epidemiology and Seasonality of Human Seasonal Coronaviruses: A Systematic Review

Wilson, R., Kovacs, D., Crosby, M., & Ho, A. Y. W. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae418 · Cited by 28 · see citing works

CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses

Woldemeskel, B. A., Dykema, A. G., Garliss, C. C., Cherfils, S., Smith, K. N., & Blankson, J. N. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156083 · Cited by 28 · see citing works

Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice

Alves, R. P. D. S., Timis, J., Miller, R., Valentine, K. M., Pinto, P. B. A., Gonzalez, A., Regla-Nava, J. Á., Maule, E., Nguyen, M. N., Shafee, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45043-2 · Cited by 28 · see citing works

HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic

Simula, E. R., Manca, M. A., Jasemi, S., Uzzau, S., Rubino, S., Manchia, P., Bitti, A., Palermo, M., & Sechi, L. A. (2020) · Microorganisms · doi:10.3390/microorganisms8121993 · Cited by 27 · see citing works

Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders

Chau, C. Y. C., Chow, L. L. W., Sridhar, S., & Shih, K. C. (2021) · Ophthalmology and Therapy · doi:10.1007/s40123-021-00338-1 · Cited by 27 · see citing works

Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis

Du, P.-X., Chou, Y.-Y., Santos, H. M., Keskin, B. B., Hsieh, M.-H., Ho, T., Wang, J., Lin, Y., & Syu, G. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00614 · Cited by 27 · see citing works

Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors

Rovito, R., Augello, M., Ben-Haim, A., Bono, V., Monforte, A. D., & Marchetti, G. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912336 · Cited by 27 · see citing works

Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases

Herman, J. D., Atyeo, C. G., Zur, Y., Cook, C., Patel, N. J., Vanni, K. M. M., Kowalski, E., Qian, G., Srivatsan, S., Shadick, N. A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf6598 · Cited by 26 · see citing works

Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning

Röltgen, K., & Boyd, S. D. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-042754 · Cited by 25 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses

Lawrenz, J., Xie, Q., Zech, F., Weil, T., Seidel, A., Krnavek, D., van der Hoek, L., Münch, J., Müller, J. A., & Kirchhoff, F. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac057 · Cited by 25 · see citing works

Inducing broad-based immunity against viruses with pandemic potential

Sette, A., & Saphire, E. O. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.010 · Cited by 24 · see citing works

Recent Infection With HCoV-OC43 Is Associated With Protection Against Sars-Cov-2 Infection

Lavell, A. H. A., Sikkens, J. J., Edridge, A. W. D., van der Straten, K., Sechan, F., Oomen, M., Buis, D. T. P., Schinkel, M., Burger, J. A., Poniman, M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105105 · Cited by 24 · see citing works

Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults

Samandari, T., Ongalo, J., McCarthy, K. D., Biegon, R., Madiega, P. A., Mithika, A., Orinda, J., Mboya, G., Mwaura, P., Anzala, O. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170011 · Cited by 24 · see citing works

Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers

Jackson-Thompson, B. M., Goguet, E., Laing, E. D., Olsen, C. H., Pollett, S. D., Hollis-Perry, M., Maiolatesi, S. E., Illinik, L., Ramsey, K. F., Reyes, A. E., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06233-1 · Cited by 23 · see citing works

Isolation of Antibodies Against the Spike Protein of SARS-CoV from Pig Serum for Competitive Immunoassay

Jung, J., Bong, J.-H., Kim, T. H., Sung, J. S., Lee, C., Kang, M., Kim, H. O., Shin, H., & Pyun, J. (2021) · BioChip Journal · doi:10.1007/s13206-021-00033-0 · Cited by 22 · see citing works

The immune response as a double‐edged sword: The lesson learnt during the COVID ‐19 pandemic

Agrati, C., Carsetti, R., Bordoni, V., Sacchi, A., Quintarelli, C., Locatelli, F., Ippolito, G., & Capobianchi, M. R. (2022) · Immunology · doi:10.1111/imm.13564 · Cited by 22 · see citing works

Targets of influenza human T-cell response are mostly conserved in H5N1

Sidney, J., Kim, A.-R., de Vries, R. D., Peters, B., Meade, P. S., Krammer, F., Grifoni, A., & Sette, A. (2024) · mBio · doi:10.1128/mbio.03479-24 · Cited by 22 · see citing works

An evaluation of patients with a previous endemic coronavirus infection during the COVID‐19 pandemic

Otlu, B., Yakupoğulları, Y., Tanrıverdi, E. S., & Bayındır, Y. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26942 · Cited by 3 · see citing works

Systematically Mapping Clinical Features of Infections With Classical Endemic Human Coronaviruses

Li, P., Ikram, A., Peppelenbosch, M. P., Ma, Z., & Pan, Q. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1386 · Cited by 15 · see citing works

Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies

Bean, D. J., Liang, Y. M., Avila, F., He, X., Asundi, A., & Sagar, M. (2025) · Journal of Virology · doi:10.1128/jvi.00550-25 · Cited by 4 · see citing works

Recent Endemic Coronavirus Infection Associates With Higher SARS-CoV-2 Cross-Reactive Fc Receptor Binding AntibodiesPreprint

Bean, D. J., Liang, Y. M., & Sagar, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.23.619886

Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidence

Bean, D. J., Monroe, J., Liang, Y. M., Borberg, E., Senussi, Y., Swank, Z., Chalise, S., Walt, D. R., Weinberg, J., & Sagar, M. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.ado7588 · Cited by 19 · see citing works